Company Filing History:
5 out of 5 
4 out of 33 
1 out of 1 Years Active: 2016-2020
Title: The Innovative Contributions of Christopher Twitty
Introduction
Christopher Twitty is a notable inventor based in Solana Beach, California. He has made significant strides in the field of medical technology, particularly in cancer treatment. With a total of 5 patents to his name, Twitty's work focuses on developing innovative solutions that can potentially revolutionize cancer therapies.
Latest Patents
One of Twitty's latest patents is titled "Allogeneic Autophagosome-Enriched Composition for the Treatment of Disease." This patent presents a method for screening cells that produce allogeneic autophagosome-enriched compositions. These compositions are capable of inducing the expression of a selective marker on a subpopulation of peripheral blood mononuclear cells. The method involves contacting a cell with a proteasome inhibitor and a lysosome inhibitor, harvesting the resulting autophagosomes, and determining their molecular signature. By selecting cells that divert Toll-like receptor agonists and molecular chaperones to the harvested autophagosomes, enriched populations can be generated. This innovation may lead to the development of an allogeneic, off-the-shelf cancer vaccine, which could stimulate a targeted immune response in patients with various tumor types.
Career Highlights
Throughout his career, Christopher Twitty has worked with several organizations that focus on healthcare and biotechnology. Notable companies include Ubivac, LLC and Providence Health & Services in Oregon. His contributions in these roles have been instrumental in advancing research and development in cancer treatment.
Collaborations
Twitty has collaborated with esteemed professionals in his field, including Hong-Ming Hu and Bernard A. Fox. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Christopher Twitty's work exemplifies the spirit of innovation in the medical field. His patents and collaborations highlight his commitment to developing effective cancer treatments. As he continues to advance his research, the potential impact of his inventions on patient care remains significant.